Questions discussed in this category
Most patients with PGNMID have no detectable disease in their marrow or blood and urine protein cannot adequately be monitored.
Are there specific guidelines for managing this patient population?
Since free light chains are removed by dialysis and SPEP can also be impacted, is there a reliable way to monitor patients with ESRD and MM?
If there are light chain deposits on the kidney, is that conclusive of MGRS?
2104120638207761833018089132366518
Papers discussed in this category
European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2021 Dec 06
Kidney international, 2018-07
BMC nephrology, 2019-02-14